Viewing Study NCT00215605


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-03-02 @ 5:52 PM
Study NCT ID: NCT00215605
Status: COMPLETED
Last Update Posted: 2013-02-27
First Post: 2005-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies
Sponsor: Exelixis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module